# aTyr Pharma, Inc. (ATYR): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for aTyr Pharma, Inc. (ATYR) is 6/100, ranked against 24,000+ stocks in 35 markets (Quality 15, Value 37, Momentum 23, each scored against its sector).

- StockRank: 6/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 15, Value 37, Momentum 23: each a 0-100 percentile within Healthcare.
- Position: #24,804 overall, #2,435 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 0.1534 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 50K.

Source: https://moatmap.ai/stock/ATYR
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker